BerGenBio ASA (OSL:BGBIO)
1.818
+0.118 (6.92%)
Apr 1, 2025, 3:20 PM CET
BerGenBio ASA Revenue
In the year 2024, BerGenBio ASA had annual revenue of 848.00K NOK with 139.55% growth. BerGenBio ASA had revenue of 681.00K in the quarter ending December 31, 2024, with 92.37% growth.
Revenue
848.00K
Revenue Growth
+139.55%
P/S Ratio
75.61
Revenue / Employee
56.53K
Employees
15
Market Cap
71.04M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 848.00K | 494.00K | 139.55% |
Dec 31, 2023 | 354.00K | -35.00K | -9.00% |
Dec 31, 2022 | 389.00K | -385.00K | -49.74% |
Dec 31, 2021 | 774.00K | 173.00K | 28.79% |
Dec 31, 2020 | 601.00K | -8.30M | -93.25% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Medistim ASA | 562.60M |
Nordhealth AS | 537.23M |
Photocure ASA | 525.39M |
Vistin Pharma ASA | 429.50M |
Hofseth BioCare ASA | 265.54M |
Omda AS | 426.27M |
ArcticZymes Technologies ASA | 108.11M |
Nykode Therapeutics AS | 104.04M |
BerGenBio ASA News
- 4 weeks ago - BerGenBio ASA (STU:7BG0) Q4 2024 Earnings Call Highlights: Strategic Review and Financial ... - GuruFocus